1 / 30

Presented By Eric Winer at 2014 ASCO Annual Meeting

Breast Plenary Abstracts<br />How Do These Studies Impact Clinical Practice Today and in the Years Ahead?<br />. Presented By Eric Winer at 2014 ASCO Annual Meeting.

sabin
Télécharger la présentation

Presented By Eric Winer at 2014 ASCO Annual Meeting

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Breast Plenary Abstracts<br />How Do These Studies Impact Clinical Practice Today and in the Years Ahead?<br /> Presented By Eric Winer at 2014 ASCO Annual Meeting

  2. First results from the phase III ALTTO trial (BIG 02-06; NCCTG 063D) comparing one year of anti-HER2 therapy with lapatinib alone (L), trastuzumab alone (T), their sequence (TL) or their combination (L + T) in the adjuvant treatment of HER2-positive <br />early breast cancer (EBC) Presented By Eric Winer at 2014 ASCO Annual Meeting

  3. N9831/B-31 Disease-Free Survival Presented By Eric Winer at 2014 ASCO Annual Meeting

  4. Pathologic Response in Neo-ALTTO Presented By Eric Winer at 2014 ASCO Annual Meeting

  5. CALGB 40601 (TH vs TL vs THL) Presented By Eric Winer at 2014 ASCO Annual Meeting

  6. Adjuvant Lapatinib (ALTTO) Schema Presented By Eric Winer at 2014 ASCO Annual Meeting

  7. Disease Free Survival (DFS) Analysis Presented By Eric Winer at 2014 ASCO Annual Meeting

  8. Disease Free Survival By Hormone Receptor Status Presented By Eric Winer at 2014 ASCO Annual Meeting

  9. Slide 9 Presented By Eric Winer at 2014 ASCO Annual Meeting

  10. Overall Survival (OS) Analysis Presented By Eric Winer at 2014 ASCO Annual Meeting

  11. Main Differences In AEs By Treatment Arm Presented By Eric Winer at 2014 ASCO Annual Meeting

  12. Thoughts About ALTTO Presented By Eric Winer at 2014 ASCO Annual Meeting

  13. Further Implications for Research and Practice Presented By Eric Winer at 2014 ASCO Annual Meeting

  14. Why Improvement in Pathologic Complete Response May Not Lead to Change in DFS Presented By Eric Winer at 2014 ASCO Annual Meeting

  15. Randomized Comparison of Adjuvant Aromatase Inhibitor <br />Exemestane plus Ovarian Function Suppression<br /> vs Tamoxifen plus Ovarian Function Suppression<br />in Premenopausal Women <br />with Hormone Receptor Positive Early Breast Cancer: <br />Joint Analysis of IBCSG TEXT and SOFT Presented By Eric Winer at 2014 ASCO Annual Meeting

  16. Study Schemas (Total N=4690) Presented By Eric Winer at 2014 ASCO Annual Meeting

  17. Improved DFS with Exemestane + OFS vs Tamoxifen + OFS Presented By Eric Winer at 2014 ASCO Annual Meeting

  18. Sites of First Failure Presented By Eric Winer at 2014 ASCO Annual Meeting

  19. Overall Survival at 5 Years Presented By Eric Winer at 2014 ASCO Annual Meeting

  20. Women Who Did Not Receive Chemotherapy Presented By Eric Winer at 2014 ASCO Annual Meeting

  21. Selected Adverse Events Presented By Eric Winer at 2014 ASCO Annual Meeting

  22. Adverse Events and QOL Presented By Eric Winer at 2014 ASCO Annual Meeting

  23. Slide 23 Presented By Eric Winer at 2014 ASCO Annual Meeting

  24. Does Ovarian Suppression Add To Tamoxifen In Premenopasual Women?<br />Findings FromThe LHRH Meta-Analysis<br /> Presented By Eric Winer at 2014 ASCO Annual Meeting

  25. Slide 25 Presented By Eric Winer at 2014 ASCO Annual Meeting

  26. Primary End Point: Disease-Free Survival<br />No Significant Difference Between TAM and ANA Presented By Eric Winer at 2014 ASCO Annual Meeting

  27. Is OS + AI The New Standard of Care? Presented By Eric Winer at 2014 ASCO Annual Meeting

  28. What To Consider When You Go Home (1) Presented By Eric Winer at 2014 ASCO Annual Meeting

  29. What To Consider When You Go Home (2) Presented By Eric Winer at 2014 ASCO Annual Meeting

  30. Thank you Presented By Eric Winer at 2014 ASCO Annual Meeting

More Related